Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cryoport (CYRX) EBITDA (2016 - 2025)

Cryoport (CYRX) has disclosed EBITDA for 16 consecutive years, with $20.0 million as the latest value for Q4 2025.

  • Quarterly EBITDA rose 257.07% to $20.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.0 million through Dec 2025, up 92.57% year-over-year, with the annual reading at -$6.8 million for FY2025, 94.45% up from the prior year.
  • EBITDA for Q4 2025 was $20.0 million at Cryoport, up from -$9.9 million in the prior quarter.
  • The five-year high for EBITDA was $27.6 million in Q4 2023, with the low at -$78.0 million in Q2 2024.
  • Average EBITDA over 5 years is -$9.9 million, with a median of -$9.6 million recorded in 2025.
  • The sharpest move saw EBITDA tumbled 584.68% in 2022, then soared 350.13% in 2023.
  • Over 5 years, EBITDA stood at -$8.4 million in 2021, then crashed by 31.97% to -$11.0 million in 2022, then skyrocketed by 350.13% to $27.6 million in 2023, then tumbled by 146.17% to -$12.7 million in 2024, then soared by 257.07% to $20.0 million in 2025.
  • According to Business Quant data, EBITDA over the past three periods came in at $20.0 million, -$9.9 million, and -$9.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.